Director Jeffrey Sherman notified the Company of his retirement from the Board effective at the 2026 Annual Meeting, prompting a Board size reduction from eight to seven directors.
Key takeaways
Dr. Jeffrey Sherman will retire from the Board and not stand for reelection at the 2026 Annual Meeting.
Sherman has served as a director since 2021 and sits on the Compensation and Nominating Committees.
The Board approved a reduction in size from eight to seven directors, effective upon Sherman's departure.
The retirement is not due to any disagreement with the Company regarding operations, policies, or practices.